Search results
Showing 2116 to 2130 of 8926 results
Tideglusib for treating congenital or childhood onset myotonic dystrophy [ID3915]
Awaiting development Reference number: GID-TA10791 Expected publication date: TBC
Plinabulin with docetaxel for previously treated advanced non-small-cell lung cancer [ID3895]
Awaiting development Reference number: GID-TA10776 Expected publication date: TBC
Bupivacaine–meloxicam for treating postoperative pain [ID2728]
Awaiting development Reference number: GID-TA10716 Expected publication date: TBC
Dusquetide for treating oral mucositis during chemoradiation for head and neck cancer [ID3830]
Awaiting development Reference number: GID-TA10715 Expected publication date: TBC
Sarizotan for the treatment of respiratory symptoms associated with Rett syndrome [ID1506]
Awaiting development Reference number: GID-TA10662 Expected publication date: TBC
Cabotegravir with rilpivirine for the oral treatment of HIV-1 [ID3731]
Awaiting development Reference number: GID-TA10604 Expected publication date: TBC
Gosuranemab for treating progressive supranuclear palsy [ID1607]
Awaiting development Reference number: GID-TA10553 Expected publication date: TBC
Awaiting development Reference number: GID-QS10129 Expected publication date: TBC
Infant, children and young people's experience of health care
Awaiting development Reference number: GID-QS10102 Expected publication date: TBC
Awaiting development Reference number: GID-QS10100 Expected publication date: TBC
Vulnerable populations: strategies for tackling inequalities
Awaiting development Reference number: GID-QS10124 Expected publication date: TBC
Awaiting development Reference number: GID-QS10099 Expected publication date: TBC
Awaiting development Reference number: GID-QS10109 Expected publication date: TBC
Awaiting development Reference number: GID-QS10105 Expected publication date: TBC
Awaiting development Reference number: GID-QS10089 Expected publication date: TBC